Application of Stability Indicating HPTLC Method for Quantitative Determination of Escitalopram Oxalate in Pharmaceutical Dosage Form
 
More details
Hide details
1
Department of Pharmaceutical Chemistry, Bharati Vidyapeeth University, Poona College of Pharmacy, Pune, Maharashtra, India 411038
2
Centre for Material Characterisation, National Chemical Laboratory, Pune, Maharashtra, India 411008
CORRESPONDING AUTHOR
Sunil R. Dhaneshwar   

Department of Pharmaceutical Chemistry, Bharati Vidyapeeth University, Poona College of Pharmacy, Pune, Maharashtra, India 411038
Online publication date: 2007-06-15
Publication date: 2007-06-15
 
Eurasian J Anal Chem 2007;2(2):101–117
 
KEYWORDS
ABSTRACT
A sensitive, selective, precise and stability indicating high-performance thin-layer chromatographic method of analysis of escitalopram oxalate both as a bulk drug and in formulations was developed and validated. The method employed TLC aluminium plates precoated with silica gel 60F-254 as the stationary phase. The solvent system consisted of toluene: acetone: ethanol: ammonia (5:1:1:0.2 v/v/v/v). This system was found to give compact spots for escitalopram oxalate (Rf value of 0.50±0.02). Escitalopram oxalate was subjected to acid and alkali hydrolysis, oxidation, dry heat treatment and photodegradation. Also the peaks of degraded products were well resolved from the pure drug with significantly different Rf values. Densitometric analysis of escitalopram oxalate was carried out in the absorbance mode at 239 nm. The linear regression analysis data for the calibration plots showed good linear relationship with concentration range of 200–1200 ng.spot-1. The mean value of correlation coefficient, slope and intercept were 0.9987±0.236, 4.186 ±1.53 and 594.8 ±0.856, respectively. The method was validated for precision, robustness and recovery. The limits of detection and quantitation were 20 and 50 ng.spot-1, respectively. Statistical analysis proves that the method is repeatable and selective for the estimation of the said drug. As the method could effectively separate the drug from its degradation products, it can be employed as a stability indicating one.
 
REFERENCES (16)
1.
Burke W J, (2002) Expert Opinion on Investigational Drugs. 11(10):1477-86.
 
2.
Matsui E, Hoshino M, Matsui A, Okahira A, (1995) Simultaneous determination of citalopram and its metabolites by high-performance liquid chromatography with column switching and fluorescence detection by direct plasma injection. J Chromatogr B Biomed Appl. 668(2):299-307.
 
3.
Haupt D, (1996) Determination of citalopram enantiomers in human plasma by liquid chromatographic separation on a Chiral-AGP column. J Chromatogr B Biomed Appl. 685(2):299-305.
 
4.
Olesen O V, Linnet K, (1996) Simplified high-performance liquid chromatographic method for the determination of citalopram and desmethylcitalopram in serum without interference from commonly used psychotropic drugs and their metabolites. J Chromatogr B Biomed Appl. 675(1):83.
 
5.
Jones A W, Holmgren A, Kuqelberg F C, (2007) Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results. Ther Drug Monit. 29(2):248-60.
 
6.
Kristoffersen F, Bugge A, Lundanes E, Slordal L, Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection (1999) J Chromatogr B Biomed Appl. 734(2):229-46.
 
7.
Carlson B, Norlander B, (1997) Solid-phase extraction with end-capped C2 columns for the routine measurement of racemic citalopram and metabolites in plasma by highperformance liquid chromatography. J Chromatogr B Biomed Sci Appl. 702(1-2):234.
 
8.
Macek J, Ptacek P, (2001) Rapid determination of citalopram in human plasma by highperformance liquid chromatography. J Chromatogr B Biomed Sci Appl. 755(1-2):279-85.
 
9.
Roberto M, Salvatore F , Vincenzo P, Maria A (2003) Enantiomeric separation of citalopram and its metabolites by capillary electrophoresis. Electrophoresis 24 (15): 2608- 2616.
 
10.
Skibinski R, Misztal G, (2005) Determination of citalopram in tablets by HPLC, densitometric HPTLC, and video densitometric HPTLC methods Journal of Liquid Chromatography & Related Technologies 28 (2): 313-324.
 
11.
ICH, Q1A Stability Testing of New Drug Substances and Products, International Conference on Harmonization, Geneva, October 1993.
 
12.
Sethi P D, (1996) High Performance Thin Layer Chromatography, Quantitative Analysis of Pharmaceutical Formulations, 2 nd edition, CBS Publishers and distributors, New Delhi.
 
13.
Thin Layer Chromatography, (2002) Monograph 2.2.27, European Pharmacopoeia, Council of Europe, 3638 pp.
 
14.
ICH, Q2A Validation of Analytical Procedure: Methodology International Conference on Harmonization, Geneva, October 1994.
 
15.
ICH, Q2B Validation of Analytical Procedure: Methodology International Conference on Harmonization, Geneva, March 1996.
 
16.
ICH Guidance on Analytical Method Validation, in: Proceedings of the International Convention on Quality for the Pharmaceutical Industry, Toronto, Canada, September 2002.
 
eISSN:1306-3057